发明名称 Management of breakthrough bleeding in extended hormonal contraceptive regimens
摘要 <p>Disclosed is a method for oral contraception in a woman comprising the following monophasic, extended, cyclic regimen: (1) administering to said woman an oral contraceptive, which comprises 20llg of ethinyl estradiol and 3mg of drospirenone, daily for a first period of 24 days, and thereafter administering said oral contraceptive daily for a second period of a maximum of96 days during which (a) said woman initiates a break of3-6 days in which the oral contraceptive is not administered, or (b) if no such break is initiated within said maximum of 96 days, a break period of 3 -6 days is taken at the end of the 96 day period, and (2) after said break period, administering said oral contraceptive with an administrationlbreak pattern in accordance with (1) above, wherein a second period is at least one day long.</p>
申请公布号 NZ586107(A) 申请公布日期 2012.05.25
申请号 NZ20050586107 申请日期 2005.04.29
申请人 BAYER SCHERING PHARMA AKTIENGESELLSCHAFT 发明人 SACHSE, ANDREAS
分类号 A61K31/57;A61K31/56;A61K31/565;A61K31/567;A61K31/575;A61K31/585;A61P15/18 主分类号 A61K31/57
代理机构 代理人
主权项
地址